Upregulation of Yes‑associated protein and transcriptional co‑activator with PDZ‑binding motif influences the behavior of LOVO human colon adenocarcinoma cells

  • Authors:
    • Yu Li
    • Lan Li
    • Min Zhu
    • Limin Ye
    • Qian Yang
  • View Affiliations

  • Published online on: August 18, 2017     https://doi.org/10.3892/etm.2017.4962
  • Pages: 3831-3835
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to investigate the role of Yes‑associated protein (YAP) and transcriptional co‑activator with PDZ‑binding motif (TAZ) in the LOVO human colon adenocarcinoma cell line and explore the underlying mechanisms. First, the expression levels of YAP and TAZ were detected in LOVO cells using reverse‑transcription quantitative PCR, and the results suggested that YAP and TAZ were faintly expressed in LOVO cells. To investigate the exact role of YAP and TAZ in LOVO cells, stable YAP‑ and/or TAZ‑overexpressing LOVO cell lines were established using YAP and/or TAZ expression plasmids. An MTT assay and flow cytometry were used to assess cell proliferation and apoptosis, respectively. The results indicated that compared with the control, YAP or TAZ overexpression significantly increased the proliferation ability of LOVO cells, while apoptosis was significantly decreased. Furthermore, the expression of the tumor‑associated proteins connective tissue growth factor and cysteine‑rich angiogenic inducer 61, which have critical roles in facilitating cancer cell proliferation, migration and invasion, were found to be upregulated following upregulation of YAP and TAZ. In addition, the expression of cell apoptosis‑associated protein B‑cell lymphoma 2 (Bcl‑2) was significantly increased, while Bcl‑2‑associated X protein and caspase‑3 were inhibited by YAP or TAZ overexpression. All of these effects were amplified when YAP and TAZ were co‑overexpressed. In conclusion, YAP and TAZ function as tumor promoters in human colon carcinoma, and upregulation of YAP and TAZ influences the behavior of LOVO colon adenocarcinoma cells via regulating tumor‑associated gene expression.

Related Articles

Journal Cover

October-2017
Volume 14 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li Y, Li L, Zhu M, Ye L and Yang Q: Upregulation of Yes‑associated protein and transcriptional co‑activator with PDZ‑binding motif influences the behavior of LOVO human colon adenocarcinoma cells. Exp Ther Med 14: 3831-3835, 2017
APA
Li, Y., Li, L., Zhu, M., Ye, L., & Yang, Q. (2017). Upregulation of Yes‑associated protein and transcriptional co‑activator with PDZ‑binding motif influences the behavior of LOVO human colon adenocarcinoma cells. Experimental and Therapeutic Medicine, 14, 3831-3835. https://doi.org/10.3892/etm.2017.4962
MLA
Li, Y., Li, L., Zhu, M., Ye, L., Yang, Q."Upregulation of Yes‑associated protein and transcriptional co‑activator with PDZ‑binding motif influences the behavior of LOVO human colon adenocarcinoma cells". Experimental and Therapeutic Medicine 14.4 (2017): 3831-3835.
Chicago
Li, Y., Li, L., Zhu, M., Ye, L., Yang, Q."Upregulation of Yes‑associated protein and transcriptional co‑activator with PDZ‑binding motif influences the behavior of LOVO human colon adenocarcinoma cells". Experimental and Therapeutic Medicine 14, no. 4 (2017): 3831-3835. https://doi.org/10.3892/etm.2017.4962